VCEL

#1745
Vericel Corporation
35.6800
-0.31%
セクター:
ベース:
利益通貨:
日中レンジ
35.6800
35.6800
1年のレンジ
33.5800
43.0000
1日の変化
-0.31%
月次変化
-3.02%
6か月変化
-1.84%
1年の変化
-1.84%
以前の終値
35.7900
Open
35.6800
Bid
Ask
Low
35.6800
High
35.6800
ボリューム
88
Open full chart

Financials

Overview 明細書 Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.7931 B
  • Employee 357
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
274.55
Price to sales ratio
11.96
Dividends per share
—
Dividend yield %
—

Vericel Corporation

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

ニュース